No headlines found.
Evogene Schedules Fourth Quarter 2024 Financial Results Release
PRNewswire (Thu, 20-Feb 7:00 AM ET)
AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease
PRNewswire (Thu, 13-Feb 8:00 AM ET)
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
Evogene Ltd. - trades on the NASDAQ stock market under the symbol EVGN.
As of March 4, 2025, EVGN stock price declined to $1.33 with 10,917 million shares trading.
EVGN has a beta of 0.66, meaning it tends to be less sensitive to market movements. EVGN has a correlation of 0.01 to the broad based SPY ETF.
EVGN has a market cap of $7.14 million. This is considered a Sub-Micro Cap stock.
Last quarter Evogene Ltd. - reported $2 million in Revenue and -$1.31 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.30.
In the last 3 years, EVGN traded as high as $16.20 and as low as $1.20.
EVGN has underperformed the market in the last year with a price return of -86.4% while the SPY ETF gained +13.9%. EVGN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.5% and -14.0%, respectively, while the SPY returned -4.2% and -5.4%, respectively.
EVGN support price is $1.34 and resistance is $1.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EVGN shares will trade within this expected range on the day.